ANI Pharmaceuticals (ANIP) Stock Chart & Stock Price History $90.00 +1.26 (+1.42%) Closing price 04:00 PM EasternExtended Trading$89.99 -0.01 (-0.01%) As of 05:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANI Pharmaceuticals Stock Price Performance The ANI Pharmaceuticals (ANIP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 52.03%, with a year-to-date return of 62.81%. In the past month, the stock has increased 38.06%, reflecting recent market activity. As of the latest close, ANI Pharmaceuticals traded at $88.74 with a market cap of $1.92 billion and volume of 1.25 million shares. Five years ago, the stock traded at $32.40, representing a 177.78% increase over that period. At the time, it had a market cap of $407.65 million and a volume of 65,833 shares. Receive ANIP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ANI Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+10.46%1 Month Performance+38.06%3 Month Performance+49.08%Year-To-Date Performance+62.81%1 Year Performance+52.03%5 Year Performance+177.78% ANIP Stock Chart for Thursday, August, 14, 2025 ANIP Chart by TradingView ANI Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/14/2025$88.74$90.00+1.42%$90.23$88.30604,501 shs$1.95 billion08/13/2025$88.34$88.74+0.45%$90.23$87.871.25 million shs$1.92 billion08/12/2025$84.88$88.34+4.08%$88.36$84.041.43 million shs$1.91 billion08/11/2025$81.48$84.88+4.17%$87.95$81.441.67 million shs$1.84 billion08/08/2025$69.01$81.48+18.07%$83.80$76.992.10 million shs$1.77 billion08/07/2025$69.09$69.01-0.12%$70.96$67.98780,529 shs$1.49 billion08/06/2025$65.87$69.09+4.89%$69.71$64.99887,203 shs$1.50 billion08/05/2025$65.43$65.87+0.67%$66.18$64.69249,201 shs$1.43 billion08/04/2025$63.93$65.43+2.35%$65.57$63.67204,794 shs$1.42 billion08/01/2025$63.35$63.93+0.92%$64.38$62.68318,815 shs$1.38 billion Get the Latest News and Ratings for ANIP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ANI Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/31/2025$64.03$63.35-1.06%$65.07$62.61196,549 shs$1.37 billion07/30/2025$64.20$64.03-0.26%$66.39$63.35253,646 shs$1.39 billion07/29/2025$66.50$64.20-3.46%$67.50$64.14467,142 shs$1.39 billion07/28/2025$67.48$66.50-1.45%$68.18$66.01394,266 shs$1.44 billion07/25/2025$66.77$67.48+1.06%$67.91$65.68416,041 shs$1.46 billion07/24/2025$66.90$66.77-0.19%$67.70$66.28265,690 shs$1.45 billion07/23/2025$66.34$66.90+0.84%$68.20$65.26316,530 shs$1.45 billion07/22/2025$65.41$66.34+1.42%$66.66$64.89198,248 shs$1.44 billion07/21/2025$66.30$65.41-1.34%$66.72$64.27347,030 shs$1.42 billion07/18/2025$68.04$66.30-2.56%$68.60$66.20326,192 shs$1.44 billion07/17/2025$66.60$68.04+2.16%$68.39$65.96401,195 shs$1.47 billion07/16/2025$64.00$66.60+4.06%$66.76$63.60571,065 shs$1.44 billion07/15/2025$65.19$64.00-1.83%$65.72$64.00335,206 shs$1.39 billion07/14/2025$64.96$65.19+0.35%$65.46$64.15198,632 shs$1.41 billion Related Companies ADMA Biologics Stock Price Chart Annovis Bio Stock Price Chart Axsome Therapeutics Stock Price Chart Lantheus Stock Price Chart CRISPR Therapeutics Stock Price Chart Abivax Stock Price Chart Merus Stock Price Chart Krystal Biotech Stock Price Chart Telix Pharmaceuticals Stock Price Chart Cytokinetics Stock Price Chart Receive ANIP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ANI Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ANIP) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredJPMorgan: Gold Will Hit $4,250Gold Surges And Some Investors Are Getting Paid, But Most Are Not. Which One Do You Want to Be? Gold prices ar...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ANI Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ANI Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access